Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.64 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.64 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
| ▸ | PPARD | Q03181 | 1/20 | 0.47 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.47 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1506633 | 1.00 | GPR84 (0.64) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL28337079 | 0.83 | GPR84 (0.58) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL3989518 | 0.82 | GPR84 (0.56) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL11452262 | 0.79 | GPR84 (0.69) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL28916782 | 0.79 | GPR84 (0.69) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL2709599 | 0.79 | GPR84 (1.00) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL22842 | 0.79 | GPR84 (1.00) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL525619 | 0.79 | GPR84 (1.00) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL524494 | 0.79 | GPR84 (1.00) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL2933185 | 0.79 | GPR84 (1.00) | GPR84FFAR1FFAR4MAPTLCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260130370-A1 | PLANT ACTIVATOR | IBIDEN CO., LTD. (JP) | 2026-05-14 | — | — | US | claimed |
| US-20190033313-A1 | METHODS AND SYSTEMS FOR DETECTING MELANOMA | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2019-01-31 | — | — | US | claimed |
| US-20180271046-A1 | BARLEY LIPOXYGENASE 1 GENE, METHOD OF SELECTING BARLEY VARIETY, MATERIAL OF MALT ALCOHOLIC DRINKS AND PROCESS FOR PRODUCING MALT ALCOHOLIC DRINK | SAPPORO BREWERIES LIMITED (JP) | 2018-09-27 | — | — | US | claimed |
| US-20170295738-A1 | BARLEY LIPOXYGENASE 1 GENE, METHOD OF SELECTING BARLEY VARIETY, MATERIAL OF MALT ALCOHOLIC DRINKS AND PROCESS FOR PRODUCING MALT ALCOHOLIC DRINK | SAPPORO BREWERIES LIMITED (JP) | 2017-10-19 | — | — | US | claimed |
| WO-2016196743-A1 | METHODS AND SYSTEMS FOR DETECTING MELANOMA | THE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2016-12-08 | — | — | WO | claimed |
| US-20160017104-A1 | Benzene Polycarboxylic Acid Compounds and Their Use as Drug | RDINNOVATION APS (DK) | 2016-01-21 | — | — | US | claimed |
| EP-2831151-A1 | BENZENE POLYCARBOXYLIC ACID COMPOUNDS AND THEIR USE AS DRUG | RDInnovation ApS (DK) | 2015-02-04 | — | — | EP | claimed |
| WO-2013143549-A1 | BENZENE POLYCARBOXYLIC ACID COMPOUNDS AND THEIR USE AS DRUG | RDINNOVATION APS (DK) | 2013-10-03 | — | — | WO | claimed |
| US-20130129862-A1 | BARLEY LIPOXYGENASE 1 GENE, METHOD OF SELECTING BARLEY VARIETY, MATERIAL OF MALT ALCOHOLIC DRINKS AND PROCESS FOR PRODUCING MALT ALCOHOLIC DRINK | SAPPORO BREWERIES LIMITED (JP) | 2013-05-23 | — | — | US | claimed |
| US-20090285932-A1 | BARLEY LIPOXYGENASE 1 GENE, METHOD OF SELECTING BARLEY VARIETY, MATERIAL OF MALT ALCOHOLIC DRINKS AND PROCESS FOR PRODUCING MALT ALCOHOLIC DRINK | SAPPORO BREWERIES LIMITED (JP) | 2009-11-19 | — | — | US | claimed |
| US-20260130370-A1 | PLANT ACTIVATOR | IBIDEN CO., LTD. (JP) | 2026-05-14 | — | — | US | disclosed |
| WO-2025094894-A1 | PLANT ACTIVATOR | イビデン株式会社 | 2025-05-08 | — | — | WO | disclosed |
| EP-4335293-A1 | PLANT ACTIVATOR | IBIDEN CO., LTD. (JP) | 2024-03-13 | — | — | EP | disclosed |
| US-20230380422-A1 | PLANT ACTIVATOR | IBIDEN CO., LTD. (JP) | 2023-11-30 | — | — | US | disclosed |
| WO-2023146984-A1 | LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2023-08-03 | — | — | WO | disclosed |
| US-5342976-A | Long chain omega-hydroxy fatty acid or a carboxy-substituted derivative; imparts barrier function to prevent moisture loss | ELIZABETH ARDEN CO., DIVISION OF CONOPCO, INC. (US) | 1994-08-30 | — | — | US | disclosed |
| US-5202357-A | Skin barrier | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1993-04-13 | — | — | US | disclosed |
| US-4950688-A | CONTROLLING SKIN BARRIER FUNCTION; HYDROXY FATTY ACID OR ESTER | CONOPCO, INC. (US) | 1990-08-21 | — | — | US | disclosed |
| EP-0097059-B1 | SKIN TREATMENT COMPOSITIONS | UNILEVER N.V. (NL) | 1989-10-25 | — | — | EP | disclosed |
| EP-0097059-A2 | Skin treatment compositions | UNILEVER N.V. (NL) | 1983-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230380422-A1 | PLANT ACTIVATOR | HAO2, HAO1, HACL2 | GPR84 195/4885FFAR1 37/4885FFAR4 125/4885 |
| US-20260130370-A1 | PLANT ACTIVATOR | HAO2, EBP, HAO1 | GPR84 833/4885FFAR1 44/4885FFAR4 193/4885 |
| US-20160017104-A1 | Benzene Polycarboxylic Acid Compounds and Their Use as Drug | PAH, HPD, PLOD2 | GPR84 2203/4885FFAR1 1709/4885FFAR4 1870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.